Sun Pharmaceutical Industries Q2 Results

  • BSE: 524715
  • NSE: SUNPHARMA
  • ISIN: INE044A01036
  • Sector: Biotechnology & Drugs
BSE
1,593.6514.40 (0.91%)
Volume36.22 K
Updated: Thu 18 Jul, 2024 | 15:50:03
NSE
1,594.2514.95 (0.95%)
Volume1.67 M
Updated: Thu 18 Jul, 2024 | 15:40:37
Today: 1,570.30
1,596.85
52-Wk: 1,063.80
1,638.70

Q2 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Sun Pharmaceutical Industries Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 23Jun 23QoQ Comp
    Total Revenue 12,192.4111,940.842.11%
    Selling/ General/ Admin Expenses Total 2,364.362,402.04-1.57%
    Depreciation/ Amortization 632.82651.32-2.84%
    Other Operating Expenses Total 3,827.493,450.9010.91%
    Total Operating Expense 9,611.769,585.300.28%
    Operating Income 2,580.652,355.549.56%
    Net Income Before Taxes 2,790.882,481.1412.48%
    Net Income 2,375.512,022.5417.45%
    Diluted Normalized EPS 9.909.494.34%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts